Navigation Links
Four-way Dengue Vaccine a 'success', Say Scientists

Researchers in the United States have developed a method that could lead to a single vaccine against all four types of the dengue// virus.

The dengue virus causes dengue hemorrhagic fever, shock and encephalitis. The four types of virus are all sufficiently different that individuals vaccinated against one virus type are still vulnerable to infection by the others.

There is currently no commercially available vaccine for protection against all types of dengue virus.

But John Dong of the Medical University of South Carolina, United States, and colleagues have developed a method that could lead to a safe and effective vaccine for all four types of the virus.

They produced a pair of synthetic vaccines, each containing genes from two of the four virus types. These successfully mimicked natural infection in mice, inducing an immune response against each of the four virus types at once.

The research was published in the February issue of the journal Clinical and Vaccine Immunology.

According to Dong, the synthetic vaccine demonstrated "100 per cent efficacy" in protecting the mice against all four dengue viruses. He added that the vaccine had also demonstrated safety in preclinical toxicology studies.

Dong told SciDev,Net that a further study on non-human primates has been conducted and will soon be submitted to a scientific journal for publication by colleagues at the US-based Naval Medical Research Center.

Prida Malasit of the Medical Biotechnology Unit in Bangkok, Thailand, welcomed the development. "There is no doubt on the importance of having the vaccine" he said.

He added that controlling dengue viruses was becoming a "formidable task for every country, not only for developing countries" because of rapidly expanding urbanisation and international travel.

Source-Bio-Bio Technology
'"/>




Page: 1

Related medicine news :

1. Dengue Outbreak in Kolkata, Four Dead
2. Dengue in Delhi – 26 Cases reported and 3 dea
3. Dengue fever in Delhi after the Monsoon
4. Dengue Claims 15 Lives In West Bengal
5. Dengue Epidemic in West Bengal: Over 1000 New Cases and 15 dead
6. 45 People die in West Bengal due to Dengue and suspected Japanese Encephalitis
7. Vaccine For Dengue Fever On Trial In Asia-Pacific
8. Dengue Fever Claims Five Lives In Pakistan
9. Fear Of Dengue Epidemic Looms Large: Fever Kills Five in Pakistan
10. Delhi Launches Special Drive to Check Dengue Spread
11. MCD Takes Steps To Prevent, Control Dengue
Post Your Comments:
(Date:5/12/2008)...ynchronized Slides at 5pm Today, LAWRENCE, Mass.,... Inc.,(Nasdaq: NXTM ), a leading manufacturer of ...financial results for the first quarter ended Marc...08 were $31.0 million, compared to,$8.4 million in...e fourth,quarter of 2007. Revenues in the in-cente...
(Date:5/12/2008)...all/ - SXC Health Solutions, Corp.,(NASDAQ: SXCI ...ts,management services and healthcare IT solutions...Shareholders will be held on Monday, May 12, 2008 ...t the Marriott Downtown, 540,North Michigan Avenue...bcast live. To access the webcast go to:, http:/...
(Date:5/12/2008)...inia Commonwealth University School of Medicine ha...million from the National Institutes of Healths Na...nt to examine polycystic ovary syndrome, a disorde...5 million women. , Polycystic ovary syndrome, or...ular menstrual cycles, excess facial and body hair...
(Date:5/12/2008)...y safety and quality of technically ...ay 12 /PRNewswire/ -- C5 Medical Werks, a leading ...ce industry, has submitted a 510(k),pre-market not... (FDA) for,its new technical ceramic dental compon...zirconium material ideally suited to meet the high...
Breaking Medicine News(10 mins):Health News:NxStage Medical Reports First Quarter 2008 Results 2Health News:NxStage Medical Reports First Quarter 2008 Results 3Health News:NxStage Medical Reports First Quarter 2008 Results 4Health News:NxStage Medical Reports First Quarter 2008 Results 5Health News:NxStage Medical Reports First Quarter 2008 Results 6Health News:NxStage Medical Reports First Quarter 2008 Results 7Health News:NxStage Medical Reports First Quarter 2008 Results 8Health News:NxStage Medical Reports First Quarter 2008 Results 9Health News:NxStage Medical Reports First Quarter 2008 Results 10Health News:NxStage Medical Reports First Quarter 2008 Results 11Health News:NIH grant to support Translational Research Center for PCOS 2Health News:C5 Medical Werks Applies for Clearance, Certification and Licensing for the Global Marketing of ZirDent(TM) Ceramic CAD/CAM Dental Blocks 2
...k of Hepatitis-A among students of Jiangxi Univers...cern to health officials in the province.// This ... resulted in the hospitalization of 64 students, a... Xinhua News Agency reports that the students who ...
...dvances in technology, new high technology based t...re is being designed by researchers of Johns Hopki...ole medical procedure a lot more safe and effectiv...t that could enable surgeons, operating in the nar...
...s at the University of Pennsylvania School of Medi... translates blood flow into gene expression. The//...ryonic development a transcription factor called K...ls, is activated by rapid, pulsed blood flow, as r...
...a government Wednesday amended the rules governing... in a bid to regulate them.// The state cabinet d...f school managements, students and employees, an o...ool managements will now be required to provide ad...
Other Medicine News:Health News:Snake Like Robots Designed to Assist Surgeons 2Health News:Snake Like Robots Designed to Assist Surgeons 3Health News:How Blood Flow Dictates Gene Expression 2
(Date:5/12/2008)...lts show promising neurological recovery in severe...y patients treated with Cethrin, HOPKINTON, Mass....euticals, Inc. (Nasdaq: ALSE ) today announced 12...trial of Cethrin, a proprietary recombinant,protei...restore motor and,sensory function after spinal co...
(Date:5/12/2008)...LANTA, May 12 /- CryoLife, ... and tissue processing company, today announced,th...ral allograft heart,valve in a patient at the Clev...e Navia, a cardiac surgeon with the Heart and Vasc...od used to process the combination aortic-mitral h...
(Date:5/9/2008)...NGKOK, Thailand, May 9 /PRNewswire-USNewswire/ -- ...y for the Protection of Animals (WSPA),is on stand...e struck,Myanmar to assess and then relieve the su...rs depend on for food and their livelihoods., W...griculture,Organization of the United Nations (FAO...
(Date:5/9/2008)...ATTLE, May 9 /PRNewswire-USNewswire/ -- The risk o...gn prostatic hyperplasia (BPH), can be,reduced by ...intaining a,normal weight and eating a healthy die...ncer Prevention Program at Fred Hutchinson Cancer ...dies that suggest men need not,feel helpless again...
Breaking Medicine Technology:Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 2Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 3Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 5CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic 2CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic 3Animals That Cyclone Survivors Depend on Need Help Now 2Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 2Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 3Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 4PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 1097 1PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 1097 2PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 1097 3PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 1097 4PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 1097 5Frequently Asked Questions When Considering a Colorectal Cancer Screening Test From the American College of Gastroenterology 3013 1Frequently Asked Questions When Considering a Colorectal Cancer Screening Test From the American College of Gastroenterology 3013 2Frequently Asked Questions When Considering a Colorectal Cancer Screening Test From the American College of Gastroenterology 3013 3Study Rates Heart Health of Popular Diet Plans 3010 1Study Rates Heart Health of Popular Diet Plans 3010 2Study Rates Heart Health of Popular Diet Plans 3010 3Study Rates Heart Health of Popular Diet Plans 3010 4St Davids Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders 3007 1St Davids Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders 3007 2St Davids Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders 3007 3
...Impact of Pain on Sleep Interference, INDIANAPOLIS... a,pooled analysis of three studies suggest that i...ge, or diabetic peripheral neuropathy,who are tre...in,both average daily pain and night pain severity...rference than in those patients,taking sugar pill....
.../PRNewswire/ -- Bayer HealthCare,Pharmaceuticals a...es with Betaseron(R) (interferon beta-1b), present...s (AAN) 59th Annual Meeting,demonstrating early e...satisfaction with treatment in patients with relap...vely, these studies highlight the important clinic...
Other Medicine Technology:Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 2Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 3Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 4Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 6Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4
...le pulse oximetry monitoring system compatible wit...nters. Extremely rugged and cost-effective.The BC...ly delivers pulse oximetry wherever spot-checking ...tpatient clinics and hospitals. In fact, its ergon...
The BCI 3180 Pulse Oximeter is a cost-effective, stand-alone monitor that delivers fast, reliable SpO 2 pulse rate and pulse strength measurements of patients from neonate to adult. This AC or batt
...git Finger Oximeter is a Pulse Oximeter and Sensor...e rate and pulse strength measurements on patients...large LED display, one button keypad and auto powe...it ideal for emergency, hospital or clinical envir...
...S. Food and Drug Administration (FDA) has granted ...s (IOL) for cataract patients with and without pre... apodized diffractive technology to give patients ... and distance) that greatly increases their indepe...
Medicine Products: